Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Asker Healthcare Group AB ( (SE:ASKER) ) is now available.
Asker Healthcare Group has announced the acquisition of Oudshoorn Chirurgische Techniek B.V., a leading distributor of medical devices in orthopaedics and trauma in the Netherlands. This strategic acquisition is expected to enhance Asker’s offerings to hospitals and private clinics by adding new product categories and expertise for operating rooms, thereby strengthening its position in the healthcare sector. The acquisition is anticipated to be completed in early September 2025 and is expected to positively impact the group’s EBITA margin.
The most recent analyst rating on (SE:ASKER) stock is a Hold with a SEK144.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare company that partners with caregivers and patients across Europe, providing medical products and solutions. The group focuses on improving patient outcomes, reducing the total cost of care, and ensuring a fair and sustainable value chain. With over 4,000 employees in 17 countries, Asker Healthcare Group generates revenues amounting to SEK 16 billion.
Average Trading Volume: 441,508
Technical Sentiment Signal: Strong Buy
Current Market Cap: SEK38.16B
See more data about ASKER stock on TipRanks’ Stock Analysis page.